Latest Story

Pfizer to acquire weight-loss start-up Metsera in $7.3bn deal

By Abigail Townsend

Date: Monday 22 Sep 2025

(Sharecast News) - Pfizer Inc has agreed to buy biotech Metsera in multi-billion dollar deal, the US drugs giant confirmed on Monday, giving it a foothold in the booming weight-loss sector and sending shares in the start-up soaring.
Under the terms of the deal, Pfizer will pay $47.40 per share in...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page